Thailand’s Bold Race to Vaccinate 70% of Its People by September
In the heart of Bangkok, the health minister, Anutin Charnvirakul, rolled out a daring plan: give at least one dose of a COVID‑19 vaccine to 70 % of the nation’s 66 million residents by the end of September.
This comes after the country’s health system has been scrambling to secure shots from a buffet of brands—Sinovac, AstraZeneca, Pfizer, Johnson & Johnson, and Moderna—when a new, stubborn strain has sparked a surge that’s nearly quadrupling cases and multiplying deaths sixfold since early April.
Key Points from the Health Minister’s Speech
- Focus on “first shots” to hit the 70 % target.
- Assurance that a second dose won’t be a problem—there’ll be plenty of leftovers.
- Goal of reaching herd immunity by year‑end, but the timeline has faced criticism for a slow vaccine bang‑in and over‑reliance on AstraZeneca.
What’s the Current Status?
So far, about 1.5 million people (a drop in the bucket) have received a first dose. Those early recipients include healthcare heroes and folks with chronic conditions.
Thailand has just signed up for AstraZeneca shots that are ready to roll out next month, thanks to local production. It’s also got Sinovac, Pfizer/BioNTech, Johnson & Johnson, and Moderna on the table.
Why the Urgency?
The latest spike of cases has pushed the nation to turn over the “tapped” switch for accelerated vaccinations. Every new critical case is another reason to keep the needles moving.
With the strategy laid out, the government is hoping that 70 % will receive that much-needed first jab by September, creating a stronger shield across the country before the icy winter of December.
